Concepedia

Giselle Chamberlain

GC

Statistics

Publications

14

Citations

2.9K

H-Index

14

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Wellcome Trust

Juvenile Diabetes Research Foundation

University of Cambridge

Brighton and Sussex Medical School

Giselle Chamberlain is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, immunology, and genetics.

Publications per year

2002–2021

14

Publications

14

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

Hironori Ueda, Joanna M. M. Howson, Laura Esposito et al. · Nature · 2003 · 2.2K citations

, , +12

Murine Mesenchymal Stem Cells Exhibit a Restricted Repertoire of Functional Chemokine Receptors: Comparison with Human

Giselle Chamberlain, Karina T. Wright, Antal Rot et al. · PLoS ONE · 2008 · 121 citations · Full text

, , +15

Fine Mapping, Gene Content, Comparative Sequencing, and Expression Analyses Support <i>Ctla4</i> and <i>Nramp1</i> as Candidates for <i>Idd5.1</i> and <i>Idd5.2</i> in the Nonobese Diabetic Mouse

Linda S. Wicker, Giselle Chamberlain, Kara Hunter et al. · The Journal of Immunology · 2004 · 112 citations · Full text

, , +9

Mesenchymal Stem Cells Exhibit Firm Adhesion, Crawling, Spreading and Transmigration across Aortic Endothelial Cells: Effects of Chemokines and Shear

Giselle Chamberlain, Helen K. Smith, G. Ed Rainger et al. · PLoS ONE · 2011 · 107 citations · Full text

, , +17

Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A

Karina T. Wright, Wagih El Masri, Aheed Osman et al. · Biochemical and Biophysical Research Communications · 2007 · 76 citations

, , +16

1–5 of 14